Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Noxious odor substances represent a broad category of volatile chemical compounds, such as thiols, amines, and carboxylic acids, that elicit unpleasant or harmful sensory experiences. These substances are detected by the olfactory system through Olfactory Receptors (G protein-coupled receptors) and the trigeminal system via Transient Receptor Potential (TRP) channels like TRPA1 and TRPV1 (PMID: 17094042, 25313083). Their primary biological role is to act as warning signals for environmental hazards, decay, or toxicity, triggering avoidance behaviors in humans and animals (PMID: 21915011). While not a single therapeutic target, these substances are clinically significant in the context of sensory hypersensitivity, respiratory exacerbations in asthma, and environmental health. Therapeutic approaches typically involve neutralizing the substances using adsorbents or masking agents, or developing antagonists for the specific ion channels they activate to mitigate irritation and pain (PMID: 30050315).
Neutralization of volatile molecules through adsorption, complexation, or pharmacological antagonism of sensory receptors such as TRPA1 and TRPV1.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Noxious odor substances.